Active Ingredient: GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE
Proprietary Name: PREVDUO
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 0.6MG/3ML (0.2MG/ML);3MG/3ML (1MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216903
Product Number: 001
Approval Date: Feb 23, 2023
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
